Table 3 Outcome, indication, use and assessment of aminoglycosides in the group of patients with S. aureus endocarditis
|  | Survivors (n = 20) | Non survivors (n = 5) | p |
|---|---|---|---|
Indication of aminoglycosides | 19/20 | 4/5 | = 0.26 |
Delivery of aminoglycosides | 15/20 | 2/5 | = 0.12 |
Use of aminoglycosides in Patients with indication | 14/19 (73.6%) | 1/4 (25%) | = 0.07 |
Aminoglycosides conformity | 14/20 (70%) | 1/5 (20%) | <  0.05 |